CHRISTINE HOUSTON: Open Payments
NPI 1841601721 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 12 payments from 7 companies in 2025. Trend: 2023 $142 · 2024 $445 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 5 | $159 |
| GENZYME CORPORATION | 1 | $121 |
| ANI Pharmaceuticals, Inc. | 2 | $41 |
| Viatris Specialty LLC | 1 | $31 |
| United Therapeutics Corporation | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: QUTENZA, DUPIXENT, PURIFIED CORTROPHIN GEL, YUPELRI, Tyvaso, ACTHAR, BREZTRI.
Industry payments across OH — which companies pay providers there.
